CD8A and myeloid sarcoma: While several T cell subsets are known to perpetuate inflammation in MS and in many experimental models of MS, particularly in acute phases of disease, mice that lack CD4+ and CD8+ T cells have significant deficits in remyelination (Bieber et al., 2003), highlighting the complicated nature of neuro-immune interactions ongoing in MS.